Merck & Company Inc (NYSE:MRK)
over-valued
by 9%
| Website | https://www.merck.com |
| Sector | Health Care |
| Industry | Pharmaceuticals |
| Fiscal Year End | December |
| Market Cap | $278B |
| Beta | 0.37 |
| Dividends per share | $2.76 |
| Current Price | $109.07 |
| Autochartist™ Valuation | $99.00 |
| Conclusion |
over-valued by -9%
|
